Baebies, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Baebies, Inc.
- Regulatory records
- 2
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 2 FDA records to the applicant name Baebies, Inc.. The collection includes 2 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 30, 2026 to Sep 11, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QOF appears in 2 of the 2 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 25 Alexandria Way,, Durham, NC, 27703, US. Recorded on K261837, decision dated Sep 11, 2026.
Device categories in this collection
Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Baebies, Inc. | 510(k) clearance | Sep 11, 2026 | FDA | |
| Baebies, Inc. | 510(k) clearance | Mar 30, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.

